Advanced search
Publication Cover
Leukemia & Lymphoma Volume 33, 1999 - Issue 3-4
Submit an article Journal homepage
50
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Dexa-BEAM is not Effective in Patients with Relapsed or Resistant Aggressive High-Grade Non-Hodgkin's Lymphoma

M. Reiser First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
A. Josting First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
P. Dias Wickramanayake First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
A. Draube First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
C. Scheid First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
H. Tesch First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
J. Wolf First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
,
V. Diehl First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
&
A. Engert First Department of Internal Medicine, University Hospital, Köln Joseph-Stelzmann-Str.9, 50924, Köln, Germany
 show all
Pages 305-312 | Accepted 01 Jul 1998, Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Niels Murawski, Carsten Zwick & Michael Pfreundschuh. (2010) Unresolved issues in diffuse large B-cell lymphomas. Expert Review of Anticancer Therapy 10:3, pages 387-402.
Read now
Johannes Atta, Kai U. Chow, Eckhart Weidmann, Paris S. Mitrou, Dieter Hoelzer & Hans Martin. (2007) Dexa-BEAM as salvage therapy in patients with primary refractory aggressive Non-Hodgkin lymphoma. Leukemia & Lymphoma 48:2, pages 349-356.
Read now
Nicola Di Renzo, Maura Brugiatelli, Antonella Montanini, Maria Luigia Vigliotti, Giulia Cervetti, Anna Marina Liberati, Stefano Luminari, Pierangelo Spedini, Gianfranco Giglio & Massimo Federico. (2006) Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. Leukemia & Lymphoma 47:3, pages 473-479.
Read now

Articles from other publishers (10)

A. K. Smolyaninova, A. V. Belyayeva, Yu. V. Sidorova, N. G. Gabeeva, S. A. Tatarnikova, D. S. Badmazhapova, D. A. Koroleva, E. G. Gemdzhian, A. M. Kovrigina, A. B. Sudarikov, E. E. Niculina, E. S. Nesterova, T. N. Obukhova & E. E. Zvonkov. (2023) High-dose chemotherapy with transplantation of autologous hematopoietic stem cells in the first line of follicular lymphoma therapy. Russian journal of hematology and transfusiology 68:3, pages 344-362.
Crossref
Carsten Zwick, Niels Murawski & Michael Pfreundschuh. (2010) Rituximab in High-Grade Lymphoma. Seminars in Hematology 47:2, pages 148-155.
Crossref
Carsten Zwick, Josef Birkmann, Norma Peter, Heinrich Bodenstein, Roland Fuchs, Mathias Hänel, Marcel Reiser, Manfred Hensel, Michael Clemens, Samira Zeynalova, Marita Ziepert & Michael Pfreundschuh. (2008) Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Annals of Hematology 87:9, pages 717-726.
Crossref
A Spencer, K Reed & C Arthur. (2007) Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim. Internal Medicine Journal 0:0, pages 070602000936001-???.
Crossref
Ulrike Heider & Orhan Sezer. 2007. Facharzt Hämatologie Onkologie. Facharzt Hämatologie Onkologie 463 491 .
Jerkeman M.Leppä S.Kvaløy S.Holte H.. (2004) ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma - the Nordic Lymphoma Group experience. European Journal of Haematology 73:3, pages 179-182.
Crossref
H. Nückel, J. Dürig & U. Dührsen. (2003) Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas. Annals of Hematology 82:8, pages 481-486.
Crossref
Luis Villela, Armando L�pez-Guillermo, Silvia Montoto, Susana Rives, Francesc Bosch, Mar�a Perales, Ana Ferrer, Jordi Esteve, Lluis Colomo, El�as Campo & Emilio Montserrat. (2001) Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens. Cancer 91:8, pages 1557-1562.
Crossref
Ralph J. Hauke & James O. Armitage. (2000) Treatment of non-Hodgkin lymphoma. Current Opinion in Oncology 12:5, pages 412-418.
Crossref
Craig H. MoskowitzJoseph R. BertinoJill R. GlassmanEric E. HedrickSonia HunteNancy Coady-LyonsDavid B. AgusAndre GoyJoseph JurcicAriela NoyJames O'BrienCarol S. PortlockDavid S. StrausBarrett ChildsRichard FrankJoachim YahalomDaniel FilippaDiane LouieStephen D. NimerAndrew D. Zelenetz. (1999) Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 17:12, pages 3776-3785.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.